Table 1 The characteristics of the selected patients
NSLN negative | NSLN positive | |||||
|---|---|---|---|---|---|---|
Patient ID | 84816 | 94948 | 67161 | 76948 | 86923 | 94812 |
Tumor type | IDC | IDC | IDC | IDC | IDC | IDC |
Tumor grade | MD | MD | MD | MD | MD | MD |
Tumor size (cm) | 1.5 | 1 | 3 | 3 | 2 | 2.5 |
SLN (P/T) | 1/2 | 1/4 | 1/1 | 2/2 | 1/1 | 1/2 |
ALN (P/T) | 0/18 | 0/16 | 0/18 | 1/21 | 2/21 | 1/28 |
ER | 3+, >75 % | 3+, >75 % | 2+, 50–70 % | 2+, 50–75 % | 3+, >75 % | 3+, >75 % |
PR | 3+, >75 % | 1+, ~15 % | 1+, 10–30 % | 1+, 25–50 % | 2+, 50–60 % | 3+, >75 % |
HER2 | Negative | Negative | Negative | Negative | Negative | Negative |
Ki-67 | 3–5 % | 20 % | 15–20 % | 10 % | 10 % | 5–10 % |